Literature DB >> 24592013

Total and lipid bound sialic acid levels in patients with polycystic ovary syndrome.

Ali Ozcan1, Aykan Yücel1, Volkan Noyan1, Nevin Sağsöz1, Osman Cağlayan2.   

Abstract

OBJECTIVE: To evaluate serum total and lipid bound sialic acid (TSA&LBSA) levels in patients with polycystic ovary syndrome (PCOS).
MATERIAL AND METHODS: Forty women with PCOS and 35 healthy controls were enrolled in the study. Serum TSA, LBSA, follicle stimulating hormone, lutenizing hormone, estradiol, thyroid stimulating hormone, prolactin, dehydroepiandrosterone sulphate, androstenedione, free testosterone, total testosterone, 17-OH progesterone, sex hormone binding globulin, cortisol, total cholesterol, triglyceride, high density lipoprotein and low density lipoprotein were measured in each subject. Insulin resistance was estimated by fasting insulin level, fasting glucose: insulin ratio and 75-g glucose tolerance test for 2 hours.
RESULTS: Serum TSA levels were not significantly different between the groups. Serum LBSA levels were higher in patients with PCOS compared to the control group. TSA was correlated with androstenedione and HOMA-IR in the PCOS group. Positive correlations were found between LBSA and dehydroepiandrosterone sulphate in patients with PCOS. After correction for BMI, the only existing significant correlation was between LBSA and follicle stimulating hormone.
CONCLUSION: Serum LBSA levels, which has previously been found to be higher in cardiovascular diseases and diabetes mellitus, are elevated in PCOS.

Entities:  

Keywords:  Polycystic ovary syndrome; lipid bound sialic acid; risk; total sialic acid

Year:  2012        PMID: 24592013      PMCID: PMC3939142          DOI: 10.5152/jtgga.2012.08

Source DB:  PubMed          Journal:  J Turk Ger Gynecol Assoc        ISSN: 1309-0380


  26 in total

1.  Serum sialic acid levels in healthy individuals.

Authors:  V K Hangloo; I Kaul; H U Zargar
Journal:  J Postgrad Med       Date:  1990-07       Impact factor: 1.476

2.  Serum sialic acid in a random sample of the general population.

Authors:  M Pönniö; H Alho; S T Nikkari; U Olsson; U Rydberg; P Sillanaukee
Journal:  Clin Chem       Date:  1999-10       Impact factor: 8.327

3.  Measurement of sialic acid and acute phase reactant proteins in sera of patients with diabetic nephropathy.

Authors:  Y Tomino; W Inoue; M Yagame; Y Nomoto; H Sakai; K Ito; K Nagaoka; N Ikeda
Journal:  J Diabet Complications       Date:  1988 Oct-Dec

4.  A new enzymatic method for the determination of sialic acid in serum and its application for a marker of acute phase reactants.

Authors:  K Taniuchi; K Chifu; N Hayashi; Y Nakamachi; N Yamaguchi; Y Miyamoto; K Doi; S Baba; Y Uchida; Y Tsukada; T Sugimori
Journal:  Kobe J Med Sci       Date:  1981-06

5.  Lipoprotein lipid concentrations and cardiovascular risk in women with polycystic ovary syndrome.

Authors:  R A Wild; P C Painter; P B Coulson; K B Carruth; G B Ranney
Journal:  J Clin Endocrinol Metab       Date:  1985-11       Impact factor: 5.958

6.  Do hyperandrogenic women with normal menses have polycystic ovary syndrome?

Authors:  E Carmina; R A Lobo
Journal:  Fertil Steril       Date:  1999-02       Impact factor: 7.329

7.  Serum total sialic acid and lipid-associated sialic acid in normal individuals and patients with myocardial infarction, and their relationship to acute phase proteins.

Authors:  M Haq; S Haq; P Tutt; M Crook
Journal:  Ann Clin Biochem       Date:  1993-07       Impact factor: 2.057

8.  [Perchlorosoluble glycoproteins and myocardial infarct: modifications of the carbohydrate moiety (author's transl)].

Authors:  M Succari; M J Foglietti; F Percheron
Journal:  Pathol Biol (Paris)       Date:  1982-03

9.  Serum sialic acid concentration predicts both coronary heart disease and stroke mortality: multivariate analysis including 54,385 men and women during 20.5 years follow-up.

Authors:  G Lindberg; L Råstam; B Gullberg; G A Eklund
Journal:  Int J Epidemiol       Date:  1992-04       Impact factor: 7.196

10.  Total and lipid-associated serum sialic acid levels in cancer patients with different primary sites and differing degrees of metastatic involvement.

Authors:  M C Plucinsky; W M Riley; J J Prorok; J A Alhadeff
Journal:  Cancer       Date:  1986-12-15       Impact factor: 6.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.